Exceptional PAT recovery, asset quality breakthrough—capex timing risk ahead
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Buy
confidence 8/10
Grade A
Asset growth 27% beat prior 22–25% guidance. ROA trajectory on track (1.5% annualized, 2% target for year). NPA guidance trajectory credible (write-offs cleared).
Optimistic
next 1–2 quarters
Very Optimistic
multi-year
ESAF delivered exceptional profitability (PAT +238% YoY) and transformational asset quality improvement (NPA 8.5% → 2.8%) while upgrading near-term guidance (asset growth 27% vs 22–25%) and pulling forward ROA target to FY27. StratoNeXt go-live (26-Oct) enables structural scaling. Key risk: ₹1.3 Cr gold loan SMAs dependent on price stabilization, and cost inflation from capex may pressure H2 margins—management signaling 60% cost-to-income target vs current 58%.
₹1175 Cr
Revenue · +43.3% YoY₹160 Cr
Reported PAT · +238.3% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Asset growth 27% YoY, exceeds prior 22–25% guidance
METTotal business 52.4k Cr (25% YoY); net asset growth on track at 27%
Gross NPA 2.8%, net NPA 0.3%
METGross NPA 2.8% (down from 8.5% prior year); net NPA 0.3% (down from 3.8%)
Cost-to-income improved to 58%
METCost-to-income 58% Q2 FY27 vs 82% Q2 FY26—verified via operating expenses 2% QoQ growth
Emerging Household segment 134% YoY growth, 32% of advances
METEH loans 134% YoY, 5% QoQ; 32% of gross advances; good portfolio quality
PAT doubled QoQ (80 Cr Q1 → 160 Cr Q2)
METPAT 160 Cr; prior quarter 80 Cr inferred from statement—driven by NPA write-off (626 Cr) release
Loan growth 3% QoQ, NII growth ~10%
METGross advances 25% YoY; NII 643 Cr (73% YoY); QoQ moderation signaled
Earnings quality
What changed since the last call
Asset growth guidance raised
UpgradePrior 22–25%, now 27% YoY—2–5 pts upside. Driven by MARG 38% YoY, EH 134% YoY traction
ROA target pulled forward
UpgradePrior FY28 exit target, now FY27 exit; 1.5% annualized achieved, 2% full-year guidance vs 2% prior FY28 target
NIM guidance maintained
NeutralAbove 7.5% target maintained; Q2 at 8.2%. Cost of funds stable; repricing up Q3 expected but manageable
Credit cost guidance unchanged
Maintained~2% annualized for FY27 reaffirmed. Q2 interim 2.6%; expected to fall to 2% by year-end as backlogs clear
The Q&A
Amit Mehendale (Robo) pressed NII +10% growth vs 3% loan QoQ—answered by portfolio mix (MARG/EH higher-yield), NPA write-off release. Deepak Poddar (Sapphire) challenged cost inflation from StratoNeXt—answered via provisioning cushion, slippage control offsetting OPEX. Analysts generally satisfied; no major evasions.
NII growth drivers — Amit Mehendale, Robo Capital
AnsweredAsset mix shift (MARG, EH higher-yield) + NPA write-off income release. FY28 moderation expected but YoY 25% growth maintained. Growth focused on migration, not fresh volume.
Insurance profitability — Amit Mehendale, Robo Capital
PartialDraft rules released; insurance 25 Cr this quarter. Drastic reduction likely; offsetting arrangements being made to maintain portfolio.
Capital plans — Amit Mehendale, Robo Capital
PartialCapital adequacy 24%; no urgent raise needed. Tier-2 raised. Open to strategic infusion; decisions after valuations finalize.
ROA trajectory — Deepak Poddar, Sapphire Capital
AnsweredGuidance changed to 2% for FY27 full year. FY28 guidance next quarter. Slippage control and provisioning fronting support.
Cost-to-income inflation — Deepak Poddar, Sapphire Capital
AnsweredPPOP steady; slippages under control; provisioning near done. Cost-to-income 60% guidance via credit cost offset, profit growth.
Gold portfolio SMA — Raj Shah, Fident Asset Management
AnsweredPrice fluctuation in Sept–Oct. Stabilizing now; expect recovery as prices normalize. 76% LTV conservative; 100% recovery expected for SMA-0.
Geographic concentration — Deepak Poddar, Sapphire Capital
Answered99% collection efficiency so far. Not material impact yet. But monitoring drought outcome through year. Spread across 24 states; will diversify over time.
MARG/EH migration — Diwakar Rana, Prudent Equity
AnsweredSmall % migrated; majority outside MFI customer base. MSME, Agri, Retail, Gold comprise MARG. New customers outside MFI.
Deposit diversification — Diwakar Rana, Prudent Equity
AnsweredBranch network 26 states; North, East, West growing. Time and trust needed; long-term leverage on network.
Geopolitical risk — Diwakar Rana, Prudent Equity
AnsweredNRI deposits +17% YoY. No credit exposure to NRI. Absolutely no problem on this front.
Guidance
FY27 asset growth 27% YoY (raised from 22–25%)
HighTotal business tracking 52.4k Cr at 25% YoY; guidance raised on MARG/EH traction
NIM maintained above 7.5% (Q2 at 8.2%)
HighCost of funds stable; repricing capacity given rate hikes; deposit mix improving
StratoNeXt capitalization beginning; cost-to-income targeting ~60% FY27
MediumPlatform live 26-Oct; capex booked now; expects absorption into growth and cost control
Risks the call surfaced
Gold portfolio recovery
MediumSMA-0 (₹1.08k Cr) and SMA-1 (₹0.25k Cr) in MARG gold portfolio exposed to gold price fluctuation. Price drop in Sept–Oct triggered spikes. Recovery depends on price stabilization.
Geographic concentration
LowMaharashtra + Karnataka = 15–16% of portfolio. Drought affecting Maharashtra; payment collection efficiency 99% to date, but prolonged drought could impact rural microloan repayment.
StratoNeXt capex impact
MediumStratoNeXt platform go-live (26-Oct-2026) now ramping capex. Cost-to-income guidance 60% (vs current 58%) implies cost inflation H2. If capex absorption delays, cost-to-income could exceed guidance.
Loan growth moderation
LowLoan book growth 3% QoQ (vs 7% revenue growth), signaling moderation despite macro growth. Portfolio shift (MARG/EH mix) driving NII disproportionately; raw volume growth slowing.
Insurance profitability reduction
MediumInsurance income halved YoY (₹25 Cr Q2 vs ₹124 Cr FY26 full year) due to IRDA draft guidelines pending finalization. Drastic reduction likely; offsetting arrangements being formulated.
Management
Score 8/10. Clear on strategy and execution milestones (StratoNeXt, portfolio diversification). Transparent on challenges (insurance headwind, drought risk, gold SMA recovery). Some deferral on capex spend details and FY28 guidance (to next quarter). Strong track record: asset growth 27% YoY (beat 22–25%), NPA 8.5% → 2.8%, cost-to-income 82% → 58%. ROA on trajectory (1.5% annualized, 2% target). Delivered PAT 160 Cr (doubled QoQ). Slippages declining (₹87 Cr vs ₹342 Cr YoY).
1 · H2 FY27
StratoNeXt platform stabilization and cost absorption
2 · Q3–Q4 FY27
Gold price stabilization; SMA buckets (Rs. 1.3 Cr) expected recovery
3 · FY27 year-end
Credit cost convergence to 2% guidance (currently 2.6%); ROA 2% validation
Key risk: ₹1.3 Cr gold loan SMAs dependent on price stabilization, and cost inflation from capex may pressure H2 margins—management signaling 60% cost-to-income target vs current 58%.
ESAF SFB swings to ₹160 Cr standalone profit in Q2FY27, GNPA ratio nearly halves to 2.84%
revenue +43.3% · margins expanding
₹1,174.71 Cr
+43.3% YoY
₹160.17 Cr
11.54%
+23.5pp YoY
₹3.1
ESAF Small Finance Bank's standalone Q2FY27 (quarter ended September 30, 2026) swung to a net profit of ₹160.17 Cr, reversing a ₹115.81 Cr loss in Q2FY26 and up 100% sequentially from ₹80.08 Cr in Q1FY27. Interest earned rose 43.3% YoY and 7.0% QoQ to ₹1,174.71 Cr, while total income (including other income of ₹213.33 Cr) came in at ₹1,388.04 Cr. The turnaround was driven primarily by a sharp normalization in credit costs: provisions and contingencies eased to ₹147.89 Cr from ₹248.67 Cr a year earlier, even as pre-provision operating profit held at ₹362.39 Cr (OPM 30.85%, roughly flat against 31.79% in Q1FY27 but up sharply from 11.37% a year ago). Net profit margin expanded to 11.54% from -12.00% YoY and 5.95% QoQ. EPS (basic) was ₹3.10 against ₹(2.25) in the year-ago quarter and ₹1.55 in Q1FY27.
Q2 FY-2027 vs prior quarters
Asset quality improved markedly: the gross NPA ratio nearly halved to 2.84% from 5.40% in Q1FY27 (8.54% a year ago), and net NPA fell to 0.34% from 0.83% QoQ — aided by a ₹625.74 Cr technical write-off taken during H1FY27, so part of the ratio improvement is an accounting effect rather than pure recovery. Capital adequacy strengthened to 24.14% (CRAR) from 22.43% YoY, consistent with the board's move to raise Tier II capital — ₹85 Cr was raised in H1FY27 against a board-approved ₹500 Cr NCD programme flagged in September. The bank also completed a core banking system migration on October 26, 2026, days before this result. Against management's prior guidance (FY27 asset growth of 22-25%, NIM above 7.5%, credit cost toward ~2% and ROA to 2% by FY27 exit), the quarter is broadly on track on profitability and capital metrics — quarterly (non-annualised) ROA rose to 0.51% from 0.26% QoQ, consistent with the glide path to the FY27-exit target — but NIM is not disclosed in this filing and quarterly provisions still annualise to roughly 2.5% of advances, above the ~2% credit-cost goal, so that specific target isn't yet confirmed met. No management press release was available for this filing to cross-check framing, and with no analyst consensus found for this quarter (ESAF SFB carries thin sell-side coverage), the print is assessed against the bank's own prior guidance and trend rather than a street number. The next checkpoint is Q3FY27, to confirm whether credit-cost normalization and the ROA glide path hold.
The stock went into the print at ₹43.21, down 0.8% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 4 consecutive quarters.
FY27 asset growth 22–25% (on track at 27% YoY); NIM maintained above 7.5% (current 7.9%); credit cost to ~2% by year-end; ROA to 2% by FY27 exit (prior FY28 target).
— This quarter: met
W1
Credit-cost trajectory toward management's ~2% year-end target — Q2FY27 provisions of ₹147.89 Cr still annualise to roughly 2.5% of advances
W2
NIM sustaining above the guided 7.5% floor (not disclosed in this filing) — watch for disclosure in the Q3FY27 print
W3
ROA progress toward the 2% FY27-exit target — quarterly (non-annualised) ROA was 0.51% in Q2FY27 vs 0.26% in Q1FY27
Bank has no subsidiary/associate/JV so only standalone exists; no exceptional items in any period; prior-year loss was from elevated regular provisioning (not a one-off), now normalized; GNPA/NNPA improvement is partly an accounting effect of a ₹625.74 Cr technical write-off in H1FY27; NIM is not disclosed anywhere in this filing.
Asset Quality Turnaround Masks Capex Timing Risk
ESAF delivered record PAT (+238% YoY), but ₹626 Cr in one-time NPA write-offs turbo-charged the number. The real story — cost-to-income collapsed 24 points and asset quality halved — is bullish, yet StratoNeXt capex and insurance headwinds temper the outlook.
₹160 Cr
+238% YoY
NPA write-off normalizes Q1 provisions
Cost-to-income 58%
–24 pts YoY
ESAF's reported profit jumped 238% year-on-year, a headline that screams blowout. Dig into the call, and the real story emerges: ₹626 crore in NPA write-offs released provisions that flowed through the P&L, turbo-charging reported PAT. Strip that out, and the underlying business—lower costs, vastly improved asset quality, profitable growth—is genuinely strong. But the near-term picture is crowded with near-equally-weighted risks: gold loan SMAs dependent on price recovery, StratoNeXt capex now ramping, and insurance income halved due to regulatory headwind. This quarter closes an era of pure microfinance and opens one of scaled, diversified lending—if management can thread the capex needle.
The one-time boost and where it sits
Reported PAT reached ₹160 crore in Q2, up from ₹80 crore in Q1. Management noted that the full quarter benefited from the release of provisions tied to the ₹626 crore in NPA write-offs taken in the quarter—a normalization that cleared the asset quality backlog and allowed the true operating PAT to surface. Without quantifying the exact P&L impact in the call, the magnitude suggests the bulk of the QoQ doubling was one-time. That said, the underlying margin structure—NII +73% YoY despite only 25% asset growth, cost-to-income collapsing 24 points to 58%—shows genuine operating leverage being unleashed.
Claims on the call vs. what holds up
Asset growth 27% YoY beats prior 22–25% guidance
Total business ₹52.4k Cr (25% YoY); net asset growth tracking 27% per stated progress
Supported
Gross NPA down to 2.8%, net NPA to 0.3%
Gross NPA 2.8% (down from 8.5% prior year); net NPA 0.3% (down from 3.8%); ₹626 Cr write-off cleared backlog
Supported
Cost-to-income improved to 58%, major efficiency gain
Cost-to-income 58% Q2 FY27 vs 82% Q2 FY26; verified via 2% QoQ OPEX growth on 7% revenue growth
Supported
Portfolio diversification—MARG 38% YoY, EH 134% YoY
MARG ₹13.9k Cr (38% YoY, 58% of portfolio); EH ₹14.5k Cr (134% YoY, 32% of advances); both asset quality good
Supported
NIM maintained above 7.5% target; Q2 at 8.2%
NIM 8.2% Q2 (stable vs rate hikes); cost of funds unchanged; deposit repricing capacity evident
Supported
ROA on track for 2% by FY27 exit
Annualized ROA 1.5% (80% of full-year target); guidance pulled forward from prior FY28 exit target
Supported (confidence high)
What changed on this call
Asset growth raised: 22–25% → 27% YoY
ROA target pulled forward: FY28 exit → FY27 exit
Insurance income halved (IRDA draft rules)—new headwind
Cost-to-income guidance 60% FY27 (vs current 58%)
Loan growth moderation: 3% QoQ signals portfolio shift, not demand weakness
The bull-bear ledger
Asset quality turnaround (NPA 8.5% → 2.8%) is structural, not one-time
Cost-to-income 58% shows operating leverage from scale; 60% guidance achievable
MARG/EH diversification into secured lending de-risks business model
StratoNeXt platform (live 26-Oct) unlocks branch automation and faster onboarding
Reported PAT leans 50%+ on one-time NPA provision release
Insurance income halved; regulatory headwind uncertain until IRDA final ruling
Gold SMA ₹1.3 Cr recovery dependent on price stabilization; 76% LTV conservative but limited upside
Loan growth 3% QoQ suggests macro headwinds or mix shift absorption—not sustainably high
Risks, ranked by holder concern
Gold SMA recovery dependency
Medium₹1.3 Cr in SMA-0/SMA-1 gold loans tied to price stabilization. 76% LTV conservative, but price continuation drop could extend recovery timeline. If gold prices remain weak, MARG (58% of portfolio) profitability takes a hit.
StratoNeXt capex absorption and cost-to-income guidance
MediumPlatform live 26-Oct; capex now accelerating. Management targets 60% cost-to-income FY27 vs current 58%, implying cushion. If quarterly OPEX growth exceeds 5%, guidance slip is possible—and credibility takes a hit.
Insurance income regulatory headwind
MediumInsurance halved YoY (₹25 Cr Q2 vs ₹124 Cr full FY26) due to IRDA draft rules pending finalization. If drastic restrictions materialize, offsetting arrangements uncertain—near-term P&L headwind of ₹50–100 Cr possible.
Loan growth moderation
LowLoan book growth 3% QoQ vs 7% revenue growth. Mix shift (MARG/EH higher-yield) explains NII divergence, but raw volume weakness could signal macro saturation or portfolio credit risk if it persists into H2.
Geographic concentration—drought and macro shock
LowMaharashtra + Karnataka = 15–16% of portfolio. Drought announced for Maharashtra; collection efficiency 99% to date, but prolonged drought could impact rural microloan repayment. Spread across 26 states mitigates but doesn't eliminate.
How the street is positioned
ESAF trades at ₹40.8 (as of 2026-11-03), below its 20-day (SMA at ₹41.94) and 50-day (₹41.86) averages but above the 200-day (₹32.74). The stock is down 50.4% from its all-time high but up 106.69% off its 52-week low, a V-shaped recovery that held post-result. RSI at 47.2 is neutral—no overbought condition. Volume is increasing, suggesting renewed interest. In flows, FII ownership ticked up to 0.32% (from 0.01% a quarter ago, +0.31pp), a small but directional inflow from foreign institutions. DII trimmed 0.83pp to 3.80%, while promoters held firm at 63.25%. The FII uptick post-result suggests institutional validation of the asset quality narrative, but the small absolute ownership (0.32%) reflects the stock's limited foreign investor base. The net takeaway: the market is cautiously constructive post-result (price above key averages, volume lifting), but risk-off sentiment lingers—the stock hasn't broken its 52-week high and remains at a 50% discount from ATH.
The debate
What to watch next
1 · Gold price and SMA recovery
Gold SMA-0/SMA-1 buckets (₹1.3 Cr total) are the single biggest near-term pressure on MARG profitability. Q3 and Q4 will show whether ₹1k-plus per gram stabilization allows the portfolio to exit SMA status. If prices don't recover, MARG slippage could accelerate.
2 · StratoNeXt capex run-rate and cost-to-income guidance realization
Q3 FY27 will show actual capex spend post-26-Oct go-live. If quarterly OPEX growth stays 3–5% (absorbing capex) while revenue grows 8–10%, the 60% cost-to-income target is achievable. If OPEX grows 8%+, guidance slip is possible.
3 · Insurance final IRDA ruling and offsetting measures
IRDA's final guidance on insurance profitability caps is pending. Management is pre-building offsetting arrangements; Q3–Q4 earnings calls will reveal whether the offset is real or aspirational. A ₹30–50 Cr annual headwind is realistic; anything more is a surprise negative.
The number to track from here
Cost-to-income guidance of 60% for FY27 is the single most important number. It encodes all three risks (StratoNeXt capex, insurance headwind, loan growth moderation) into one metric. If ESAF delivers 58–60% cost-to-income for full FY27 despite capex, insurance drag, and macro headwinds, the thesis holds and capex is a temporary pain for long-term gain. If cost-to-income slips to 62%+, the guidance credibility fractures—and near-term re-rating will be limited.
ESAF Small Finance Bank's Q2 is a quarter of genuine operational achievement (NPA halved, cost-to-income down 24 points, ROA on track) shadowed by equally genuine near-term headwinds (gold SMA, capex, insurance). The reported profit of ₹160 crore is not a clean read—₹626 crore in one-time write-offs inflated the number—but the underlying momentum is intact. This is a steady-execution story with a capex timing risk in the next 6 months. The stock's 50% drawdown from ATH and neutral technicals offer a fair entry for holders who believe management can thread the needle; sellers are not wrong either, given the headline risks and macro uncertainty. Watch cost-to-income guidance realization in Q3–Q4 FY27 as the arbiter.